{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:46:52Z","timestamp":1794379612451,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>TBS usefulness in primary hyperparathyroidism (PHPT) management is uncertain. The primary aim was to evaluate the significance of performing Trabecular Bone Score (TBS) in addition to classical PHPT surgical recommendations. The explorative objective was to characterize bone quality in a cohort of patients with asymptomatic PHPT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From 1\/1\/2021 to 5\/31\/2024, of 265 consecutively evaluated PHPT patients, 125 met inclusion and exclusion criteria. Patients underwent complete biochemical evaluation in the same laboratory, Dual Energy X-ray Absorptiometry (DXA) at three sites, TBS with the same densitometer, and renal ultrasound. We retrospectively applied to each patient all the criteria to recommend parathyroidectomy as per the Fifth International Workshop, adding also TBS\u2009\u2264\u20091.2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Almost one-third of patients presented degraded TBS (\u2264\u20091.2), 36.0% partially degraded TBS, and 31.2% preserved TBS (\u2265\u20091.35). Mean TBS was partially degraded (1.286\u2009\u00b1\u20090.134). Osteoporotic patients had lower TBS than osteopenic patients (1.207\u2009\u00b1\u20090.101 vs. 1.27 9\u2009\u00b1\u20090.110; <jats:italic>p<\/jats:italic>\u2009&lt;.001). Patients with degraded TBS had a greater number of fragility fractures than those with TBS\u2009&gt;\u20091.2 (34.2% vs. 8.3%; <jats:italic>p<\/jats:italic>\u2009&lt;.001). In the group of osteopenic patients (34.4%), 10\/43 (23.3%) showed degraded TBS. 13 patients (10.4%) did not meet any surgical criteria, and of these, 3\/13 (23.1%) had degraded TBS and were osteopenic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>More than one-fifth of patients who did not meet the current surgical recommendations presented degraded TBS and osteopenia. The combination of degraded TBS and osteopenia as a possible new surgical recommendation could increase the number of patients who might benefit from curative parathyroidectomy, with potential reduction of fracture risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-025-02590-9","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:06:44Z","timestamp":1745557604000},"page":"1819-1828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trabecular bone score as a possible new surgical recommendation in patients with asymptomatic primary hyperparathyroidism"],"prefix":"10.1007","volume":"48","author":[{"given":"Nicol\u00f2","family":"Bisceglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Malagrin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Vandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Zavatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"2590_CR1","doi-asserted-by":"publisher","unstructured":"Bilezikian JP (2018) Primary Hyperparathyroidism, J Clin Endocrinol Metab, vol. 103, no. 11, pp. 3993\u20134004, Nov. https:\/\/doi.org\/10.1210\/jc.2018-01225","DOI":"10.1210\/jc.2018-01225"},{"key":"2590_CR2","doi-asserted-by":"publisher","unstructured":"Saponaro F et al (Nov. 2018) Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Invest 41(11):1339\u20131348. https:\/\/doi.org\/10.1007\/s40618-018-0879-z","DOI":"10.1007\/s40618-018-0879-z"},{"key":"2590_CR3","doi-asserted-by":"publisher","unstructured":"Silva BC, Cusano NE, Bilezikian JP (Jan. 2024) Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 38(1):101247. https:\/\/doi.org\/10.1016\/j.beem.2018.09.013","DOI":"10.1016\/j.beem.2018.09.013"},{"key":"2590_CR4","doi-asserted-by":"publisher","unstructured":"Palermo A et al (2024) Primary hyperparathyroidism: from guidelines to outpatient clinic, Rev Endocr Metab Disord, Oct. https:\/\/doi.org\/10.1007\/s11154-024-09899-5","DOI":"10.1007\/s11154-024-09899-5"},{"key":"2590_CR5","doi-asserted-by":"publisher","unstructured":"Minisola S et al (2022) Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism., J Bone Miner Res, vol. 37, no. 11, pp. 2315\u20132329, Nov. https:\/\/doi.org\/10.1002\/jbmr.4665","DOI":"10.1002\/jbmr.4665"},{"key":"2590_CR6","doi-asserted-by":"publisher","unstructured":"Ejlsmark-Svensson H, Rolighed L, Harsl\u00f8f T, Rejnmark L (2021) Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis., Osteoporos Int, vol. 32, no. 6, pp. 1053\u20131060, Jun. https:\/\/doi.org\/10.1007\/s00198-021-05822-9","DOI":"10.1007\/s00198-021-05822-9"},{"key":"2590_CR7","doi-asserted-by":"publisher","unstructured":"Stein EM et al (May 2013) Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res 28(5):1029\u20131040. https:\/\/doi.org\/10.1002\/jbmr.1841","DOI":"10.1002\/jbmr.1841"},{"key":"2590_CR8","doi-asserted-by":"publisher","unstructured":"Bandeira F, Cassibba S (2015) Hyperparathyroidism and Bone Health, Jul. 27, Current Medicine Group LLC 1. https:\/\/doi.org\/10.1007\/s11926-015-0523-2","DOI":"10.1007\/s11926-015-0523-2"},{"key":"2590_CR9","doi-asserted-by":"publisher","unstructured":"Silva BC et al (2014) Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image, Journal of Bone and Mineral Research, vol. 29, no. 3, pp. 518\u2013530, Mar. https:\/\/doi.org\/10.1002\/jbmr.2176","DOI":"10.1002\/jbmr.2176"},{"issue":"3","key":"2590_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jocd.2012.05.001","volume":"16","author":"R Winzenrieth","year":"2013","unstructured":"Winzenrieth R, Michelet F, Hans D (2013) Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: effects of resolution and noise. J Clin Densitom 16(3):287\u2013296. https:\/\/doi.org\/10.1016\/j.jocd.2012.05.001","journal-title":"J Clin Densitom"},{"issue":"3","key":"2590_CR11","doi-asserted-by":"publisher","first-page":"101415","DOI":"10.1016\/j.jocd.2023.101415","volume":"26","author":"WD Leslie","year":"2023","unstructured":"Leslie WD, Binkley N, Goel H, Hans D, McCloskey EV (2023) Trabecular bone score vertebral exclusions affect risk classification and treatment recommendations: the Manitoba Bmd registry. J Clin Densitom 26(3):101415. https:\/\/doi.org\/10.1016\/j.jocd.2023.101415","journal-title":"J Clin Densitom"},{"issue":"1","key":"2590_CR12","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.jocd.2023.101452","volume":"27","author":"H Goel","year":"2024","unstructured":"Goel H et al (2024) Clinical use of trabecular bone score: the 2023 ISCD official positions. J Clin Densitom 27(1):101452. https:\/\/doi.org\/10.1016\/j.jocd.2023.101452","journal-title":"J Clin Densitom"},{"key":"2590_CR13","doi-asserted-by":"publisher","unstructured":"Cianferotti L et al (2023) Bone quality in endocrine diseases: determinants and clinical relevance, J Endocrinol Invest, vol. 46, no. 7, pp. 1283\u20131304, Mar. https:\/\/doi.org\/10.1007\/s40618-023-02056-w","DOI":"10.1007\/s40618-023-02056-w"},{"key":"2590_CR14","doi-asserted-by":"publisher","unstructured":"Harvey NC et al (Sep. 2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216\u2013224. https:\/\/doi.org\/10.1016\/j.bone.2015.05.016","DOI":"10.1016\/j.bone.2015.05.016"},{"key":"2590_CR15","doi-asserted-by":"publisher","unstructured":"Hans D, \u0160te\u0148ov\u00e1 E, Lamy O The Trabecular Bone Score (TBS) Complements DXA and the FRAX as a Fracture Risk Assessment Tool in Routine Clinical Practice, Dec. 01, 2017, Current Medicine Group LLC 1. https:\/\/doi.org\/10.1007\/s11914-017-0410-z","DOI":"10.1007\/s11914-017-0410-z"},{"key":"2590_CR16","doi-asserted-by":"publisher","unstructured":"Bilezikian JP et al (2022) Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop, Nov. 01, John Wiley and Sons Inc. https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"2590_CR17","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Torres M et al (Apr. 2019) Usefulness of trabecular bone score (TBS) to identify bone fragility in patients with primary hyperparathyroidism. J Clin Densitometry 22(2):162\u2013170. https:\/\/doi.org\/10.1016\/J.JOCD.2018.06.005","DOI":"10.1016\/J.JOCD.2018.06.005"},{"key":"2590_CR18","doi-asserted-by":"publisher","unstructured":"Grigorie D, Coles D, Sucaliuc A (2018) Trabecular bone score (TBS) has a poor discriminative power for vertebral fractures in 153 Romanian patients with primary hyperparathyroidism, Acta Endocrinol (Copenh), vol. 14, no. 2, pp. 208\u2013212, Apr. https:\/\/doi.org\/10.4183\/aeb.2018.208","DOI":"10.4183\/aeb.2018.208"},{"key":"2590_CR19","doi-asserted-by":"publisher","unstructured":"Castellano E, Attanasio R, Gianotti L, Cesario F, Tassone F, Borretta G (2016) Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria. https:\/\/doi.org\/10.1210\/jc.2016-1513","DOI":"10.1210\/jc.2016-1513"},{"key":"2590_CR20","doi-asserted-by":"publisher","unstructured":"Walker MD et al (Oct. 2016) Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Osteoporos Int 27(10):3063\u20133071. https:\/\/doi.org\/10.1007\/s00198-016-3637-0","DOI":"10.1007\/s00198-016-3637-0"},{"key":"2590_CR21","doi-asserted-by":"publisher","unstructured":"Leere JS, Kruse C, Robaczyk M, Karmisholt J, Vestergaard P (2018) Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort study, Bone Rep, vol. 9, pp. 101\u2013109, Dec. https:\/\/doi.org\/10.1016\/j.bonr.2018.08.001","DOI":"10.1016\/j.bonr.2018.08.001"},{"key":"2590_CR22","doi-asserted-by":"publisher","unstructured":"Miguel GA et al (2019) Trabecular Bone Score, Bone Mineral Density and Bone Markers in Patients with Primary Hyperparathyroidism 2 Years after Parathyroidectomy, Hormone and Metabolic Research, vol. 51, no. 3, pp. 186\u2013190, Mar. https:\/\/doi.org\/10.1055\/a-0850-8679","DOI":"10.1055\/a-0850-8679"},{"key":"2590_CR23","doi-asserted-by":"publisher","unstructured":"Arboiro-Pinel R, Mah\u00edllo-Fern\u00e1ndez I, D\u00edaz-Curiel M (2022) Bone Analysis Using Trabecular Bone Score and Dual-Energy X-Ray Absorptiometry-Based 3-Dimensional Modeling in Postmenopausal Women With Primary Hyperparathyroidism, Endocrine Practice, vol. 28, no. 1, pp. 83\u201389, Jan. https:\/\/doi.org\/10.1016\/j.eprac.2021.08.006","DOI":"10.1016\/j.eprac.2021.08.006"},{"key":"2590_CR24","doi-asserted-by":"publisher","unstructured":"Romagnoli E et al (2013) \u2018Trabecular Bone Score\u2019 (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism, Bone, vol. 53, no. 1, pp. 154\u2013159, Mar. https:\/\/doi.org\/10.1016\/j.bone.2012.11.041","DOI":"10.1016\/j.bone.2012.11.041"},{"key":"2590_CR25","doi-asserted-by":"publisher","unstructured":"Eller-Vainicher C et al (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism, Eur J Endocrinol, vol. 169, no. 2, pp. 155\u2013162, Aug. https:\/\/doi.org\/10.1530\/EJE-13-0305","DOI":"10.1530\/EJE-13-0305"},{"key":"2590_CR26","doi-asserted-by":"publisher","unstructured":"Oprea TE et al (Jan. 2023) Degraded bone microarchitecture in women with PHPT\u2013Significant predictor of fracture probability. Clin Med Insights Endocrinol Diabetes 16. https:\/\/doi.org\/10.1177\/11795514221145840","DOI":"10.1177\/11795514221145840"},{"key":"2590_CR27","doi-asserted-by":"publisher","unstructured":"OV\u010cARI\u010cEK PPETRANOVI\u0106 (May 2023) Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score. Q J Nuclear Med Mol Imaging 67(2). https:\/\/doi.org\/10.23736\/S1824-4785.23.03510-0","DOI":"10.23736\/S1824-4785.23.03510-0"},{"key":"2590_CR28","doi-asserted-by":"publisher","unstructured":"Biamonte F et al (Oct. 2024) Assessment of trabecular bone score (TBS) in the prediction of vertebral fracture in postmenopausal osteoporosis. Bone p. 117307. https:\/\/doi.org\/10.1016\/j.bone.2024.117307","DOI":"10.1016\/j.bone.2024.117307"},{"key":"2590_CR29","doi-asserted-by":"publisher","unstructured":"Omichi Y et al (Jan. 2024) Can TBS reference values be a valid indicator for clinical vertebral fracture? A cross-sectional study. J Bone Min Metab 42(1):60\u201368. https:\/\/doi.org\/10.1007\/s00774-023-01476-1","DOI":"10.1007\/s00774-023-01476-1"},{"key":"2590_CR30","doi-asserted-by":"publisher","unstructured":"Vescini F et al (2023) Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism, Endocr Metab Immune Disord Drug Targets, vol. 24, no. 8, pp. 991\u20131006, Dec. https:\/\/doi.org\/10.2174\/0118715303260423231122111705","DOI":"10.2174\/0118715303260423231122111705"},{"key":"2590_CR31","doi-asserted-by":"publisher","unstructured":"Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study, Journal of Bone and Mineral Research, vol. 26, no. 11, pp. 2762\u20132769, Nov. https:\/\/doi.org\/10.1002\/jbmr.499","DOI":"10.1002\/jbmr.499"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02590-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:56:25Z","timestamp":1753948585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02590-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2590"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02590-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}